EN
HI

Akums Drugs & Pharmaceuticals Share price

AKUMS

467.9

0.00 (0.00%)
NSE
BSE
Last updated on 28 Aug, 2025 | 15:46 IST
BUYSELL
Today's High

481.00

Today's Low

464.15

52 Week Low

405.00

52 Week High

968.90

The current prices are delayed, login to your account for live prices

Akums Drugs & Pharmaceuticals Chart

Akums Drugs & Pharmaceuticals Share Key Metrics

Volume
4.54 L
Market Cap
7364.46 CR
LTQ@LTP
50@467.90
ATP
472.34
Var Margin
18.22 %
Circuit Range
421.15-514.65
Delivery %
72.7 %
Value
21.44 CR
ASM/GSM
No
Market Lot
1

Akums Drugs & Pharmaceuticals Futures & Options

Data Not Found

Akums Drugs & Pharmaceuticals Corporate Actions

DateAgenda
2025-08-08Quarterly Results
2025-05-26Audited Results

Akums Drugs & Pharmaceuticals News

No Data Found

About Akums Drugs & Pharmaceuticals

NSE : 24715  
BSE : 544222  
ISIN : INE09XN01023  

Our Company was incorporated as a public limited company under the Companies Act 1956 as ‘Akums Drugs and Pharmaceuticals Limited’ pursuant to a certificate of incorporation dated April 19 2004 issued by the RoC. Our Company received a certificate for commencement of business issued by the RoC dated May 13 2004.Major Events and Milestones:2004-Incorporation of the Company-Established first plant for oral dosage commissioned at 19 20 21 sector 6A Haridwar Uttarakhand2007-Established dedicated manufacturing site for oral liquid dosage at 22 Sector 6A Sidcul Haridwar Uttarakhand and sterile products at 2345 Sector 6B SIDCUL Haridwar Uttarakhand2009-Incorporated Maxcure Nutravedics Limited to venture into nutraceuticals2010-Dedicated a facility for hormones at 48 Sector 6A SIDCUL Haridwar Uttarakhand-Dedicated a facility for cosmetics and dermatology at 47 Sector 6A SIDCUL Haridwar Uttarakhand-Incorporated Akumentis Healthcare Limited to venture into branded formulations2011-Innovated bi-layered sustained release tablets for the first time2012-Acquired Pure and Cure Healthcare Private Limited to expand capacity and capabilities2013-Innovated tablet-in-tablet sustained release tablets for the first time-Acquired Malik Lifesciences Private Limited manufacturing sites to expand capacity and capabilities-Expanded into the African market2015-Expanded into the Asian market-Established research and development laboratory in Mumbai Maharashtra to venture into regulated market2016-Maxcure Nutravedics Limited received US-NSF certification2019-Investment by Ruby QC Investment Holdings Pte. Ltd. in our Company to become a minority shareholder2021-Acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs-Acquisition of a facility at Kotdwar Uttarakhand by Akums Healthcare Limited2022-Plant at 19 20 21 Sector 6A SIDCUL Haridwar Uttarakhand and plant at 2 3 45 Sector 6B SIDCUL Haridwar Uttarakhand accredited European Union-Good Manufacturing Practices qualifying for exports to European markets-Acquisition of a facility in Haridwar Uttarakhand by Akums Healthcare Limited and a facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited2023-Acquisition of another facility in Baddi Himachal Pradesh by Pure and Cure Healthcare Private Limited-Merger of Akums Lifesciences Limited with Pure and Cure Healthcare Private Limited

Read More

Akums Drugs & Pharmaceuticals Management

NamePosition
Mr. Sanjeev Jain Managing Director
Mr. Sandeep Jain Managing Director
View More

Akums Drugs & Pharmaceuticals FAQs

The Buying Price of Akums Drugs & Pharmaceuticals share is 467.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Akums Drugs & Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Akums Drugs & Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Akums Drugs & Pharmaceuticals shares is 21.54. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Akums Drugs & Pharmaceuticals shares is 2.36. Useful to assess the stock's value relative to its book value.

To assess Akums Drugs & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 32.74 & 3.64 with sector averages, along with growth rates and financial metrics.

The Market Cap of Akums Drugs & Pharmaceuticals is 7364.46 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Akums Drugs & Pharmaceuticals share price is 968.90 & 405.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Akums Drugs & Pharmaceuticals belongs to the Healthcare sector.